Clonal lineage tracing and parallel multiomics profiling reveal transcriptional heterogeneity induced by ARID1A deficiency
Science Advances · 2026
DOI: 10.1126/sciadv.aed7880 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Kenichi Miyata und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Epigenomics, Cancer Institute, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo 135-8550, Japan. Hauptthemen laut MEDLINE: Transcription Factors, DNA-Binding Proteins, Cell Lineage, Genetic Heterogeneity. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Takeda Science Foundation, Uehara Memorial Foundation, Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Transcriptional heterogeneity drives malignant progression, yet how it emerges within tumors remains unclear. By combining genetic perturbation and lineage tracing with parallel single-cell multiomics, we tracked the consequences of ARID1A loss within individual clonal lineages. ARID1A deficiency increased transcriptional variability both within and across clones, recurrently giving rise to diverse transcriptional profiles that did not converge on a common, coordinated pattern. This variability was accompanied by broadened chromatin accessibility at normally silenced loci and depended on residual SMARCA4 activity. Clones in which this variability was prominent showed no growth advantage under standard conditions but were preferentially recovered under specific environmental stresses and during lung colonization, a context dependence consistent with bet-hedging. Our findings suggest that loss of an epigenetic regulator can promote tumor evolution by relaxing transcriptional constraints and widening the range of phenotypes accessible to a clonal lineage, rather than by imposing a single fixed phenotype.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Cancer Epigenomics, Cancer Institute, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo 135-8550, Japan.
- Cancer Cell Communication Project, NEXT-Ganken Program, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo 135-8550, Japan.
- Cancer Cell Diversity Project, NEXT-Ganken Program, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo 135-8550, Japan.
ORCID-Profile: Kenichi Miyata, Kohei Kumegawa, Reo Maruyama
Förderung
- Takeda Science Foundation
- Uehara Memorial Foundation
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science
- Kato Memorial Bioscience Foundation
- Mochida Memorial Foundation for Medical and Pharmaceutical Research
Zitieren
APA
Miyata, K., Yang, L., Yang, Y., Kumegawa, K., & Maruyama, R. (2026). Clonal lineage tracing and parallel multiomics profiling reveal transcriptional heterogeneity induced by ARID1A deficiency. Science Advances. https://doi.org/10.1126/sciadv.aed7880
Vancouver
Miyata K, Yang L, Yang Y, Kumegawa K, Maruyama R. Clonal lineage tracing and parallel multiomics profiling reveal transcriptional heterogeneity induced by ARID1A deficiency. Science Advances. 2026. doi:10.1126/sciadv.aed7880
BibTeX
@article{Miyata2026,
author = {Miyata, Kenichi and Yang, Liying and Yang, Yuxiao and Kumegawa, Kohei and Maruyama, Reo},
title = {Clonal lineage tracing and parallel multiomics profiling reveal transcriptional heterogeneity induced by ARID1A deficiency},
journal = {Science Advances},
year = {2026},
doi = {10.1126/sciadv.aed7880}
}
EUVIMED